These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is it harmful to lower HDL levels? Henahan J JAMA; 1981 Nov; 246(20):2311, 2315. PubMed ID: 7299948 [No Abstract] [Full Text] [Related]
3. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia. Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B Artery; 1982; 10(2):88-94. PubMed ID: 7092581 [TBL] [Abstract][Full Text] [Related]
4. Probucol and ischaemic heart disease. Oliver MF Lancet; 1981 Oct; 2(8250):805. PubMed ID: 6116924 [No Abstract] [Full Text] [Related]
5. A little more information about aggravation of probucol-induced HDL-reduction by clofibrate. Yokoyama S; Yamamoto A; Kurasawa T Atherosclerosis; 1988 Mar; 70(1-2):179-81. PubMed ID: 3355613 [No Abstract] [Full Text] [Related]
6. In vitro activity of probucol on cholesteryl ester transport. Chiesa G; Franceschini G; Sirtori CR Biochim Biophys Acta; 1990 Aug; 1045(3):302-4. PubMed ID: 2386803 [TBL] [Abstract][Full Text] [Related]
7. Effects of probucol on lipoprotein protein kinetics. Nestel PJ Artery; 1982; 10(2):95-8. PubMed ID: 7092582 [TBL] [Abstract][Full Text] [Related]
8. Relation of high-density lipoproteins to coronary artery disease. Lewis B Am J Cardiol; 1983 Aug; 52(4):5B-8B. PubMed ID: 6613863 [TBL] [Abstract][Full Text] [Related]
9. Dietary fat, HDL, cholesterol, and coronary disease: one interpretation. Miller GJ; Miller NE Lancet; 1982 Dec; 2(8310):1270-1. PubMed ID: 6128562 [No Abstract] [Full Text] [Related]
12. Ultracentrifugal study of metabolic effects of probucol: plasma lipoproteins in patients with proven coronary artery disease. Opplt JJ; Bahler RC Artery; 1982; 10(2):108-30. PubMed ID: 7092579 [TBL] [Abstract][Full Text] [Related]
13. [Relation between HDL cholesterol and ECG findings]. Bergert KD; Neubert I; Krause M; Siegl P Z Gesamte Inn Med; 1981 Jul; 36(13):462-4. PubMed ID: 7281819 [TBL] [Abstract][Full Text] [Related]
14. [Probucol, HDL and inverse transport of cholesterol]. Med Clin (Barc); 1989 Oct; 93(13):22-3 p.. PubMed ID: 2695695 [No Abstract] [Full Text] [Related]
15. [How do changes in the plasma concentration of HDL induced by probucol operate?]. Med Clin (Barc); 1988 Apr; 90(13):556-7. PubMed ID: 3393042 [No Abstract] [Full Text] [Related]
17. [Pharmacology of probucol. II]. Donatelli L Clin Ter; 1984 Mar; 108(6):475-95. PubMed ID: 6233067 [No Abstract] [Full Text] [Related]
18. [Comparative effects of probucol and placebo on blood cholesterol in patients on long-term treatment (author's transl)]. Mc Caughan D Nouv Presse Med; 1980 Oct; 9(40):3018-20. PubMed ID: 7443444 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacology of probucol. I]. Donatelli L Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074 [No Abstract] [Full Text] [Related]
20. Recommendations for the treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis of the American Heart Association. Arteriosclerosis; 1984; 4(4):443A-468A. PubMed ID: 6466199 [No Abstract] [Full Text] [Related] [Next] [New Search]